Role of the EZH2 histone methyltransferase as a therapeutic target in cancer
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference51 articles.
1. Acquisition of a single EZH2 D1 domain mutation confers acquired resistance to EZH2-targeted inhibitors;Baker;Oncotarget,2015
2. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer;Bracken;EMBO J,2003
3. Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): a review of 47 cases;Callegaro-Filho;Gynecol Oncol,2015
4. Predictive value of grade for metastasis development in the main histological types of adult soft tissue sarcomas. A study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group;Coindre;Cancer,2001
5. Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines;Eskander;Int J Gynecol Cancer,2013
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PPARγ and C/EBPα enable adipocyte differentiation upon inhibition of histone methyltransferase PRC2 in malignant tumors;Journal of Biological Chemistry;2024-09
2. EZH2‐associated tumor malignancy: A prominent target for cancer treatment;Clinical Genetics;2024-06-17
3. Optimization of Bioanalytical Liquid Chromatography - Tandem Mass Spectrometric Method for Quantification of Tazemetostat: An Epithelioid Sarcoma Treatment Drug in Human Plasma;2023 12th International Conference on System Modeling & Advancement in Research Trends (SMART);2023-12-22
4. Distinct Regulation of EZH2 and its Repressive H3K27me3 Mark in Polyomavirus-Positive and -Negative Merkel Cell Carcinoma;Journal of Investigative Dermatology;2023-10
5. Chromatin remodeler Activity-Dependent Neuroprotective Protein (ADNP) contributes to syndromic autism;Clinical Epigenetics;2023-03-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3